Award
National Cancer Institute 5R35CA304457-02
Understanding and Targeting Aberrant RNA Splicing in Leukemia
Recipient
Sloan-Kettering Inst Can Research
Award Amount
$1,015,176.00
Ceiling
$1,015,176.00
Awarded
July 29, 2026
Identifier
5R35CA304457-02
NIH awarded a grant to study aberrant RNA splicing in leukemia, aiming to understand and target RNA splicing mutations using advanced biological approaches.
Description
This NIH grant supports research into the genetic and mechanistic basis of hematopoietic malignancies, focusing on RNA splicing mutations and their therapeutic targeting. The project involves transcriptomic, immunogenomic, and chemoproteomic approaches to address key biological questions.